Another day, another multibillion pharma deal - part 2
Now that the £32 billion AbbVie/Shire deal looks to be "done" (or at least for the time being), it's time to look at another potential deal brewing in the sector.
I hear GlaxoSmithKline is in the early stages of examining a multi-billion dollar takeover bid for US-based biopharmaceutical company InterMune.
Good sources tell me the FTSE 100 giant has spent the last month looking at whether to make an offer for InterMune, which specialises in making a drug to treat idiopathic pulmonary fibrosis...
Register for free to see rest of this article and all public articles from BetavilleLogin / Register